pubmed-article:15121757 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15121757 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:15121757 | lifeskim:mentions | umls-concept:C0348013 | lld:lifeskim |
pubmed-article:15121757 | lifeskim:mentions | umls-concept:C0441723 | lld:lifeskim |
pubmed-article:15121757 | lifeskim:mentions | umls-concept:C1305855 | lld:lifeskim |
pubmed-article:15121757 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
pubmed-article:15121757 | lifeskim:mentions | umls-concept:C0078257 | lld:lifeskim |
pubmed-article:15121757 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
pubmed-article:15121757 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:15121757 | pubmed:dateCreated | 2004-5-3 | lld:pubmed |
pubmed-article:15121757 | pubmed:abstractText | Vinorelbine is currently one of the most active chemotherapeutic agents. However, it is also a moderate vesicant that is well known to cause venous irritation and phlebitis. We conducted this study to identify clinical risk factors related to the incidence of venous irritation caused by peripheral vinorelbine infusion. | lld:pubmed |
pubmed-article:15121757 | pubmed:language | eng | lld:pubmed |
pubmed-article:15121757 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15121757 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15121757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15121757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15121757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15121757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15121757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15121757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15121757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15121757 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15121757 | pubmed:month | Apr | lld:pubmed |
pubmed-article:15121757 | pubmed:issn | 0368-2811 | lld:pubmed |
pubmed-article:15121757 | pubmed:author | pubmed-author:NishiwakiYuta... | lld:pubmed |
pubmed-article:15121757 | pubmed:author | pubmed-author:NihoSeijiS | lld:pubmed |
pubmed-article:15121757 | pubmed:author | pubmed-author:KakinumaRyuta... | lld:pubmed |
pubmed-article:15121757 | pubmed:author | pubmed-author:KubotaKaoruK | lld:pubmed |
pubmed-article:15121757 | pubmed:author | pubmed-author:OhmatsuHirono... | lld:pubmed |
pubmed-article:15121757 | pubmed:author | pubmed-author:GotoKoichiK | lld:pubmed |
pubmed-article:15121757 | pubmed:author | pubmed-author:YohKiyotakaK | lld:pubmed |
pubmed-article:15121757 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15121757 | pubmed:volume | 34 | lld:pubmed |
pubmed-article:15121757 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15121757 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15121757 | pubmed:pagination | 206-9 | lld:pubmed |
pubmed-article:15121757 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:meshHeading | pubmed-meshheading:15121757... | lld:pubmed |
pubmed-article:15121757 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15121757 | pubmed:articleTitle | High body mass index correlates with increased risk of venous irritation by vinorelbine infusion. | lld:pubmed |
pubmed-article:15121757 | pubmed:affiliation | Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan. kyoh@east.ncc.go.jp | lld:pubmed |
pubmed-article:15121757 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15121757 | lld:pubmed |